Motion Sickness Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064677
  • May 2021
  • Pharmaceuticals
  • 119 Pages
The Motion Sickness Drug market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Motion Sickness Drug market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered GlaxoSmithKline plc, Perrigo Company plc, Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals Inc, Myungmoon Pharm Co. Ltd, Baxter International Inc, CVS Health
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Motion Sickness Drug market along with their effects over the forecast period. Similarly, according to the region Motion Sickness Drug market research report includes the study of opportunities available in the market situation.

The Motion Sickness Drug market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Motion Sickness Drug Market:
The Motion Sickness Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. GlaxoSmithKline plc, Perrigo Company plc, Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals Inc, Myungmoon Pharm Co. Ltd, Baxter International Inc, CVS Health

Motion Sickness Drug Market Segmentation Analysis:
By Treatment Type
Anticholinergics
Antihistamines
Others
Distribution Channel
Retail Pharmacies
Online Pharmacies
Others

Global Motion Sickness Drug Market Segmentation by Regions:
In regional analysis, Motion Sickness Drug market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Motion Sickness Drug market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Motion Sickness Drug Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Motion Sickness Drug Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Motion Sickness Drug Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Motion Sickness Drug Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Motion Sickness Drug Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Motion Sickness Drug market, according to the key region.
  • To study the Motion Sickness Drug market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Motion Sickness Drug market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Motion Sickness Drug research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Motion Sickness Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Motion Sickness Drug market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Motion Sickness Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Motion Sickness Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Motion Sickness Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • GlaxoSmithKline plc
  • Perrigo Company plc
  • Prestige Consumer Healthcare Inc.
  • WellSpring Pharmaceutical Corporation
  • Caleb Pharmaceuticals Inc
  • Myungmoon Pharm Co. Ltd
  • Baxter International Inc
  • CVS Health
  • Anticholinergics
  • Antihistamines
  • Others
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Motion Sickness Drug Market Snapshot
          2.1.1. Global Motion Sickness Drug Market By Treatment Type,2019
               2.1.1.1.Anticholinergics
               2.1.1.2.Antihistamines
               2.1.1.3.Others
          2.1.2. Global Motion Sickness Drug Market By Distribution Channel,2019
               2.1.2.1.Retail Pharmacies
               2.1.2.2.Online Pharmacies
               2.1.2.3.Others
          2.1.3. Global Motion Sickness Drug Market By End-use,2019
          2.1.4. Global Motion Sickness Drug Market By Geography,2019

3. Global Motion Sickness Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Motion Sickness Drug Market Size (US$), By Treatment Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Treatment Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Treatment Type, 2020
     4.2. Global Motion Sickness Drug Market Size (US$), By Treatment Type, 2018 – 2028

5. Global Motion Sickness Drug Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Motion Sickness Drug Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Motion Sickness Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Motion Sickness Drug Market Size (US$), By End-use, 2018 – 2028

7. Global Motion Sickness Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Motion Sickness Drug Market Analysis, 2018 – 2028 
          7.2.1. North America Motion Sickness Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Motion Sickness Drug Market Size (US$), By Treatment Type, 2018 – 2028
          7.2.3. North America Motion Sickness Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Motion Sickness Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Motion Sickness Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe Motion Sickness Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Motion Sickness Drug Market Size (US$), By Treatment Type, 2018 – 2028
          7.3.3. Europe Motion Sickness Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Motion Sickness Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Motion Sickness Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Motion Sickness Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Motion Sickness Drug Market Size (US$), By Treatment Type, 2018 – 2028
          7.4.3. Asia Pacific Motion Sickness Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Motion Sickness Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Motion Sickness Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Motion Sickness Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Motion Sickness Drug Market Size (US$), By Treatment Type, 2018 – 2028
          7.5.3. Latin America Motion Sickness Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Motion Sickness Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Motion Sickness Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA Motion Sickness Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Motion Sickness Drug Market Size (US$), By Treatment Type, 2018 – 2028
          7.6.3. MEA Motion Sickness Drug Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Motion Sickness Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Motion Sickness Drug Providers
        8.4.1 GlaxoSmithKline plc
                8.4.1.1 Business Description
                8.4.1.2 GlaxoSmithKline plc Geographic Operations
                8.4.1.3 GlaxoSmithKline plc Financial Information
                8.4.1.4 GlaxoSmithKline plc Product Positions/Portfolio
                8.4.1.5 GlaxoSmithKline plc Key Developments
        8.4.2 Perrigo Company plc
                8.4.2.1 Business Description
                8.4.2.2 Perrigo Company plc Geographic Operations
                8.4.2.3 Perrigo Company plc Financial Information
                8.4.2.4 Perrigo Company plc Product Positions/Portfolio
                8.4.2.5 Perrigo Company plc Key Developments
        8.4.3 Prestige Consumer Healthcare Inc.
                8.4.3.1 Business Description
                8.4.3.2 Prestige Consumer Healthcare Inc. Geographic Operations
                8.4.3.3 Prestige Consumer Healthcare Inc. Financial Information
                8.4.3.4 Prestige Consumer Healthcare Inc. Product Positions/Portfolio
                8.4.3.5 Prestige Consumer Healthcare Inc. Key Developments
        8.4.4 WellSpring Pharmaceutical Corporation
                8.4.4.1 Business Description
                8.4.4.2 WellSpring Pharmaceutical Corporation Geographic Operations
                8.4.4.3 WellSpring Pharmaceutical Corporation Financial Information
                8.4.4.4 WellSpring Pharmaceutical Corporation Product Positions/Portfolio
                8.4.4.5 WellSpring Pharmaceutical Corporation Key Developments
        8.4.5 Caleb Pharmaceuticals Inc
                8.4.5.1 Business Description
                8.4.5.2 Caleb Pharmaceuticals Inc Geographic Operations
                8.4.5.3 Caleb Pharmaceuticals Inc Financial Information
                8.4.5.4 Caleb Pharmaceuticals Inc Product Positions/Portfolio
                8.4.5.5 Caleb Pharmaceuticals Inc Key Developments
        8.4.6 Myungmoon Pharm Co. Ltd
                8.4.6.1 Business Description
                8.4.6.2 Myungmoon Pharm Co. Ltd Geographic Operations
                8.4.6.3 Myungmoon Pharm Co. Ltd Financial Information
                8.4.6.4 Myungmoon Pharm Co. Ltd Product Positions/Portfolio
                8.4.6.5 Myungmoon Pharm Co. Ltd Key Developments
        8.4.7 Baxter International Inc
                8.4.7.1 Business Description
                8.4.7.2 Baxter International Inc Geographic Operations
                8.4.7.3 Baxter International Inc Financial Information
                8.4.7.4 Baxter International Inc Product Positions/Portfolio
                8.4.7.5 Baxter International Inc Key Developments
        8.4.8 CVS Health
                8.4.8.1 Business Description
                8.4.8.2 CVS Health Geographic Operations
                8.4.8.3 CVS Health Financial Information
                8.4.8.4 CVS Health Product Positions/Portfolio
                8.4.8.5 CVS Health Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Motion Sickness Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Motion Sickness Drug Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Motion Sickness Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Motion Sickness Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Motion Sickness Drug Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Motion Sickness Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Motion Sickness Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Motion Sickness Drug Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Motion Sickness Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Motion Sickness Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Motion Sickness Drug Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Motion Sickness Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Motion Sickness Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Motion Sickness Drug Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Motion Sickness Drug Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Motion Sickness Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Motion Sickness Drug: Market Segmentation 
FIG. 2 Global Motion Sickness Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Motion Sickness Drug Market, By Treatment Type, 2019 (US$ Mn) 
FIG. 5 Global Motion Sickness Drug Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Motion Sickness Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Motion Sickness Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Motion Sickness Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Motion Sickness Drug Providers, 2019
FIG. 11 Global Motion Sickness Drug Market Revenue Contribution, By Treatment Type, 2019 & 2028 (Value %) 
FIG. 12 Global Motion Sickness Drug Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Motion Sickness Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Motion Sickness Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Motion Sickness Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Motion Sickness Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Motion Sickness Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Motion Sickness Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Motion Sickness Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Motion Sickness Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Motion Sickness Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America Motion Sickness Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America Motion Sickness Drug Market Value, By Country, 2018 – 2028
TABLE  Europe Motion Sickness Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe Motion Sickness Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe Motion Sickness Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Motion Sickness Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Motion Sickness Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Motion Sickness Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America Motion Sickness Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Motion Sickness Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Motion Sickness Drug Market Value, By Country, 2018 – 2028
TABLE  MEA Motion Sickness Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA Motion Sickness Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA Motion Sickness Drug Market Value, By Country, 2018 – 2028
TABLE  GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Perrigo Company plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Prestige Consumer Healthcare Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  WellSpring Pharmaceutical Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Caleb Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Myungmoon Pharm Co. Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Baxter International Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CVS Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Motion Sickness Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Motion Sickness Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Motion Sickness Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Motion Sickness Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global Motion Sickness Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Motion Sickness Drug Providers, 2016
FIG.  Global Motion Sickness Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Antihistamines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Motion Sickness Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Motion Sickness Drug Market Value, 2018 – 2028, (US$ Mn)